Drug Trial Radar · NCT00664248
A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris
Last checked: Nov 19, 2026Latest source record: Apr 22, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,414
Actual
Start
Oct 2006
Primary completion
Aug 2007
Sponsor
- Lead sponsor
- Dow Pharmaceutical SciencesIndustry
- Sponsor type
- Industry
- First posted
- Apr 22, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.
Conditions
- Acne Vulgaris
Interventions
IDP-110Drug
Topical application for 12 weeks
ClindamycinDrug
Topical application for 12 weeks
Benzoyl peroxideDrug
Topical application for 12 weeks
VehicleDrug
Topical application for 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in number of lesionsTime frame: 12 weeks
Locations
35 sites in 3 countries. Site status is shown where the registry gives one.
Total Skin and Beauty Dermatology Center
Birmingham, Alabama
University of Alabama, Birmingham
Birmingham, Alabama
Medical Affiliated Research Center, Inc.
Huntsville, Alabama
Dermatology Research of Arkansas
Little Rock, Arkansas
Affiliated Research Institute - Dermatology
San Diego, California
Therapeutics Clinical Research
San Diego, California
University of California, San Diego, Pediatric and Adolescent Dermatology
San Diego, California
Solano Clinical Research
Vallejo, California
Dermatology Specialists, Inc.
Vista, California
Clinical Research Specialists
West Santa Monica, California
Cherry Creek Dermatology Research Inc.
Denver, Colorado
Longmont Medical Research Network
Longmont, Colorado
International Dermatology Research, Inc.
Miami, Florida
FXM Research
Miami, Florida
Office of Scott Glazer, MD
Buffalo Grove, Illinois
Henry Ford Medical Center
Detroit, Michigan
The Nevada Center for Dermatology
Reno, Nevada
Academic Dermatology
Albuquerque, New Mexico
Triangle Medical Research Associates
Cary, North Carolina
Unifour Medical Research Associates
Hickory, North Carolina
Wake Research Associates, LLC
Raleigh, North Carolina
New Haven Medical Research
Wilmington, North Carolina
Northwest Cutaneous Research Specialists
Portland, Oregon
Oregon Medical Center, PC
Portland, Oregon
Rivergate Dermatology
Goodlettsville, Tennessee
Dermatology Associates
Knoxville, Tennessee
Dermatology Research Associates
Nashville, Tennessee
Tennessee Clinical Research Center
Nashville, Tennessee
The Center for Skin Research
Houston, Texas
Progressive Clinical Research
San Antonio, Texas
Dermatology Resarch Center
Salt Lake City, Utah
Advanced Clinical Research - Jordan Valley
West Jordan, Utah
Advanced Healthcare
Milwaukee, Wisconsin
Dermatology and Skin Surgery Centre
Belize City, Belize
Mediprobe Research
New London, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.